Search Results - "Revets, H"

Camelid immunoglobulins and nanobody technology by Muyldermans, S., Baral, T.N., Retamozzo, V. Cortez, De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V.K., Revets, H., Rothbauer, U., Stijlemans, B., Tillib, S., Wernery, U., Wyns, L., Hassanzadeh-Ghassabeh, Gh, Saerens, D.

“…It is well established that all camelids have unique antibodies circulating in their blood. Unlike antibodies from other species, these special antibodies are…”
Get full text

Screening for enterocins and detection of hemolysin and vancomycin resistance in enterococci of different origins by De Vuyst, L., Foulquié Moreno, M.R., Revets, H.

“…The inhibitory activity of 122 out of 426 Enterococcus strains of geographically widespread origin and from different sources (food and feed, animal isolates,…”
Get full text

ABINs inhibit EGF receptor-mediated NF-κB activation and growth of EGF receptor-overexpressing tumour cells by Huang, L, Verstrepen, L, Heyninck, K, Wullaert, A, Revets, H, De Baetselier, P, Beyaert, R

“…The epidermal growth factor receptor (EGFR) is frequently overexpressed in various tumours of epidermal origin and is held responsible for tumourigenicity and…”
Get full text

Radioimmunoimaging. Advances and prospects by Van de Wiele, C, Revets, H, Mertens, N

“…The advent of biotechnology has made it possible to overcome the undesired host antiglobulin response evidenced following the injection of rodent antibodies…”
Get full text

Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma by REVETS, H, MARISSENS, D, DE WIT, S, LACOR, P, CLUMECK, N, LAUWERS, S, ZISSIS, G

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Isolation of Campylobacter concisus from feces of children with and without diarrhea by VAN ETTERIJCK, R, BREYNAERT, J, REVETS, H, DEVREKER, T, VANDENPLAS, Y, VANDAMME, P, LAUWERS, S

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania major by COTE-SIERRA, Javier, BREDAN, Amin, TOLDOS, Carmen M, STIJLEMANS, Benoit, BRYS, Lea, CORNELIS, Pierre, SEGOVIA, Manuel, DE BAETSELIER, Patrick, REVETS, Hilde

“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Nanobodies as novel agents for cancer therapy by Revets, Hilde, De Baetselier, Patrick, Muyldermans, Serge

“…Nanobodies are the smallest fragments of naturally occurring heavy-chain antibodies that have evolved to be fully functional in the absence of a light chain…”
Get more information

Efficient cancer therapy with a nanobody-based conjugate by CORTEZ-RETAMOZO, Virna, BACKMANN, Natalija, SENTER, Peter D, WERNERY, Ullrich, DE BAETSELIER, Patrick, MUYLDERMANS, Serge, REVETS, Hilde

“…Nanobodies are the smallest fragments of naturally occurring single-domain antibodies that have evolved to be fully functional in the absence of a light chain…”
Get full text

Analysis of epidemic Pseudomonas aeruginosa isolates by isoelectric focusing of pyoverdine and RAPD-PCR : modern tools for an integrated anti-nosocomial infection strategy in burn wound centres by DE VOS, D, LIM, A. JR, PIRNAY, J. P, DUINSLAEGER, L, REVETS, H, VANDERKELEN, A, HAMERS, R, CORNELIS, P

“…The Gram-negative bacterium Pseudomonas aeruginosa is an important life-threatening nosocomial pathogen in burn units. In this study we analysed epidemic P…”
Get full text

The development of nanobodies for therapeutic applications by Van Bockstaele, Femke, Holz, Josefin-Beate, Revets, Hilde

“…Evolution has been continuously honing the design of antibodies to function as specific molecular markers that are able to alert the immune system to the…”
Get more information

Eimeria species which infect the chicken contain virus-like RNA molecules by Ellis, J, Revets, H

“…There is increasing support for the presence of viruses and virus-like particles inside protozoan cells. This study describes viral-like RNA molecules that…”
Get more information

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov by Vandamme, P, Holmes, B, Vancanneyt, M, Coenye, T, Hoste, B, Coopman, R, Revets, H, Lauwers, S, Gillis, M, Kersters, K, Govan, J R

“…We performed an integrated genotypic and phenotypic analysis of 128 strains of the genera Burkholderia, Ralstonia, and Pseudomonas in order to study the…”
Get more information

Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm by Stijlemans, Benoit, Conrath, Katja, Cortez-Retamozo, Virna, Van Xong, Hoang, Wyns, Lode, Senter, Peter, Revets, Hilde, De Baetselier, Patrick, Muyldermans, Serge, Magez, Stefan

“…Antigen variation is a successful defense system adopted by several infectious agents to evade the host immune response. The principle of this defense strategy…”
Get full text

Efficient tumor targeting by single‐domain antibody fragments of camels by Cortez‐Retamozo, Virna, Lauwereys, Marc, Hassanzadeh Gh, Gholamreza, Gobert, Martine, Conrath, Katja, Muyldermans, Serge, De Baetselier, Patrick, Revets, Hilde

“…The variable domain of functional heavy chain antibodies (VHH) devoid of light chains, found in camels, constitute the smallest intact antigen‐binding domain…”
Get full text

Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium by Revets, H, Vandamme, P, Van Zeebroeck, A, De Boeck, K, Struelens, M J, Verhaegen, J, Ursi, J P, Verschraegen, G, Franckx, H, Malfroot, A, Dab, I, Lauwers, S

“…Burkholderia cepacia has become an increasingly recognized pathogen among cystic fibrosis (CF) patients and its potential role in declining pulmonary function…”
Get more information

Secretory Leukocyte Protease Inhibitor Promotes the Tumorigenic and Metastatic Potential of Cancer Cells by Devoogdt, Nick, Ghassabeh, Gholamreza Hassanzadeh, Zhang, Jing, Brys, Lea, De Baetselier, Patrick, Revets, Hilde

“…Because of their ability to inhibit proteases, protease inhibitors have generally been considered to counteract tumor progression and metastasis. However,…”
Get full text

The Wild-Derived Inbred Mouse Strain SPRET/Ei Is Resistant to LPS and Defective in IFN-β Production by Mahieu, Tina, Park, Jin Mo, Revets, Hilde, Pasche, Bastian, Lengeling, Andreas, Staelens, Jan, Wullaert, Andy, Vanlaere, Ineke, Hochepied, Tino, van Roy, Frans, Karin, Michael, Libert, Claude

“…Although activation of Toll-like receptor 4 (TLR4)-positive cells is essential for eliminating Gram-negative bacteria, overactivation of these cells by the…”
Get full text

Secretory Leukocyte Protease Inhibitor in Cancer Development by DEVOOGDT, NICK, REVETS, HILDE, GHASSABEH, GHOLAMREZA HASSANZADEH, DE BAETSELIER, PATRICK

“…: Secretory leukocyte protease inhibitor (SLPI), an epithelial‐specific serine protease inhibitor of the whey acidic protein (WAP) family, exerts broad…”
Get full text

ABINs inhibit EGF receptor-mediated NF-[kappa]B activation and growth of EGF receptor-overexpressing tumour cells by Huang, L, Verstrepen, L, Heyninck, K, Wullaert, A, Revets, H, De Baetselier, P, Beyaert, R

“…The epidermal growth factor receptor (EGFR) is frequently overexpressed in various tumours of epidermal origin and is held responsible for tumourigenicity and…”
Get full text